• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number BLIS-X1
Device Problem Contamination of Device Ingredient or Reagent (2901)
Patient Problems Eye Injury (1845); No Known Impact Or Consequence To Patient (2692)
Event Date 04/29/2019
Event Type  Injury  
Manufacturer Narrative
Investigation of this event is in progress.A follow-up report will be submitted upon completion of the investigation.
 
Event Description
It was reported that the lens was removed and replaced intra-operatively due to white matter on the lens.The incision was enlarged and the same model and diopter lens was implanted as a back-up.The patient has made a full recovery.
 
Manufacturer Narrative
The product was not returned for evaluation; consequently, no product evaluation was performed.The complaint could not be confirmed.There are several different causes that could potentially be attributed to this issue.One potential reason is that the appearance of the intraocular lens (iol) may be changed by improper manipulation with forceps.Another factor may be that some iol marks may be caused by improper additive transfer (sourced by the loading chamber).Such marks are 100% biocompatible and typically disappear after several days or weeks.A definitive root cause cannot be determined.A device history record (dhr) review could not be completed as no lot number has been provided.Based upon the complaint trend review, the volume of complaints is within the acceptable control limits and no complaint trend is observed.The trend analysis, risk analysis and directions for use review were considered acceptable, with the product performing within anticipated rates.No corrective action is necessary at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
MDR Report Key8650623
MDR Text Key146391159
Report Number0001313525-2019-00089
Device Sequence Number1
Product Code MSS
Combination Product (y/n)Y
PMA/PMN Number
K131958
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 01/01/2005,04/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBLIS-X1
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/29/2019
Supplement Dates Manufacturer Received07/12/2019
Supplement Dates FDA Received08/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ENVISTA LENS, AMVISC PLUS VISCOELASTIC; ENVISTA LENS, AMVISC PLUS VISCOELASTIC
Patient Outcome(s) Other;
Patient Age64 YR
-
-